Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Editorial

Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs

Author(s): Mohammad Amjad Kamal and Salman Akhtar

Volume 31, Issue 5, 2024

Published on: 11 September, 2023

Page: [552 - 553] Pages: 2

DOI: 10.2174/092986733105230911112507

conference banner
[1]
Talluri, S.; Kamal, M.A.; Malla, R.R. Novel computational methods for cancer drug design. Curr. Med. Chem., 2024, 31(5), 554-572.
[2]
Ghosh, A.; Ghosh, D.; Mukerjee, N. et al. The efficient activity of glabridin and its derivatives against EGFR-mediated inhibition of breast cancer. Curr. Med. Chem., 2024, 31(5), 573-594.
[3]
Shah, A.A.; Ahmad, S.; Yadav, M.K.; Raza, K.; Kamal, M.A.; Akhtar, S. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis. Curr. Med. Chem., 2024, 31(5), 595-619.
[4]
Alam, S.; Verma, S.; Fatima, K.; Luqman, S.; Srivastava, S.K.; Khan, F. Pharmacophore & QSAR guided design, synthesis, pharmacokinetics, and in vitro evaluation of curcumin analogs for anticancer activity. Curr. Med. Chem., 2024, 31(5), 620-639.
[5]
Ahmad, S. lshammari, Q.T.; Rafi, Z. et al. Generation of autoantibodies in metal-catalyzed oxidatively damaged DNA in various cancer subjects. Curr. Med. Chem., 2024, 31(5), 640-648.
[6]
Mirza, Z. Integrated high-throughput transcriptomic data identifies survivin as a potential breast cancer therapeutic biomarker. Curr. Med. Chem., 2024, 31(5), 649-663.

© 2024 Bentham Science Publishers | Privacy Policy